The current MHRA guidance on Allergan Withdrawal of Biocell Device is as follows:

“We are aware Allergan have stopped selling textured breast implants and tissue expanders and intend to withdraw remaining supply in European markets.

“There is currently no evidence of an increased risk to patients and there is no need for people who have Allergan breast implants to get them removed or have any additional clinical follow-up.

“We are monitoring the situation closely and will provide updates as necessary.”